English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/202824
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


The Resveratrol Prodrug JC19 Delays Retinal Degeneration in rd10 Mice

AuthorsValdés-Sánchez, María Lourdes; García-Delgado, Ana B.; Montero-Sánchez, Adoración; Cerda, Berta de la ; Lucas, Ricardo ; Peñalver, Pablo ; Morales, Juan C.; Bhattacharya, Shom Shanker ; Díaz-Corrales, Francisco J.
KeywordsRetinitis pigmentosa
Retinal degeneration
Sirtuin 1
Issue Date2019
PublisherSpringer Nature
CitationRetinal Degenerative Diseases. Mechanisms and Experimental Therapy 75: 457-462 (2019)
SeriesAdvances in Experimental Medicine and Biology
AbstractIt has been reported that resveratrol (RES) has a therapeutic effect in different neurodegenerative and ocular diseases. However, RES is rapidly eliminated from the organism, and high doses need to be administered resulting in potential toxic side effects. We hypothesized that a RES prodrug such as 3,4′-diglucosyl resveratrol (JC19) would reduce RES metabolism to produce a neuroprotective effect. Here, we have examined the protective effect of JC19 in an experimental mouse model of autosomal recessive RP. Rd10 mice at postnatal day 13 (P13) were subretinally injected with vehicle and two different doses of JC19. Electroretinogram (ERG) and histological evaluation were performed 15 days after injections. The amplitude of a- and b-waves was quantified in ERG recordings, and the number of photoreceptor nuclei in the outer nuclear layer was counted. In addition, the mouse retinas were immunostained with anti-rhodopsin antibodies. JC19 treatment delayed the loss of rod photoreceptor in rd10 mice, maintaining the expression of rhodopsin and preserving their electrical responses to light stimuli. The exact mechanism by which RES delays retinal degeneration in rd10 mice remains to be elucidated, but Sirtuin 1 activation could be one of the key molecular pathways involved in its neuroprotective effect.
Publisher version (URL)http://dx.doi.org/10.1007/978-3-030-27378-1_75
Identifiersdoi: 10.1007/978-3-030-27378-1_75
issn: 2214-8019
isbn: 978-3-030-27377-4
Appears in Collections:(IPBLN) Libros y partes de libros
(CABIMER) Libros y partes de libros
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.